BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3218263)

  • 1. [Development of hypertension in patients with mesangioproliferative glomerulonephritis].
    Pap I; Gärtner U
    Z Arztl Fortbild (Jena); 1988; 82(10):461-2. PubMed ID: 3218263
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
    Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
    Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long term treatment of chronic glomerulonephritis, clinical course and results of renal biopsies].
    Brass H; Lapp H; Heintz R
    Arch Klin Med; 1969; 216(4):303-23. PubMed ID: 4983036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of elevated blood pressure and proteinuria on progression of mesangioproliferative glomerulonephritis].
    Wiecek A; Strzelczyk P; Kokot F; Karkoszka H; Irzyniec T
    Pol Arch Med Wewn; 1994 Oct; 92(4):331-7. PubMed ID: 7854961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Type I and III membranoproliferative glomerulonephritis. Clinical picture and prognosis].
    Matousovic K; Rossmann P; Prát V; Chadimová M
    Cas Lek Cesk; 1990 Jun; 129(25):778-81. PubMed ID: 2393885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evolution of patients with isolated C3 mesangial glomerulonephritis.
    Calls Ginesta J; Almirall J; Torras A; Darnell A; Revert L
    Clin Nephrol; 1995 Apr; 43(4):221-5. PubMed ID: 7606875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional and morphological characteristics of a hematuric form of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Brodskiĭ MA; Makurov AI
    Klin Med (Mosk); 1990 Jun; 68(6):54-7. PubMed ID: 2214640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
    Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
    Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasorenal hypertension in nephroptosis patients].
    Kravchuk AV
    Vrach Delo; 1987 Apr; (4):77-80. PubMed ID: 3617649
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
    Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
    Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
    Cahen R; Trolliet P; Dijoud F; Megri K; François B
    Transplant Proc; 1995 Apr; 27(2):1746-7. PubMed ID: 7725484
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive factors and therapeutic approach of renovascular disease: four years' follow-up.
    Ziakka S; Ursu M; Poulikakos D; Papadopoulos C; Karakasis F; Kaperonis N; Papagalanis N
    Ren Fail; 2008; 30(10):965-70. PubMed ID: 19016147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and surgical treatment of renovascular hypertension in patients with a single kidney].
    Knjazev MD; Kipiani KB
    Z Urol Nephrol; 1985 Apr; 78(4):197-203. PubMed ID: 4013528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-electroencephalographic index dynamics as affected by electrosleep in renovascular hypertension after renal artery surgery].
    Kniazeva TA; Andreeva VM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (1):34-8. PubMed ID: 7222508
    [No Abstract]   [Full Text] [Related]  

  • 20. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
    Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.